|
Market Closed -
Nasdaq
16:00:00 2026-09-04 EDT
|
5-day change | 1st Jan Change | ||
| 17.38 USD | -0.46% |
|
-3.71% | +47.79% |
| 08-27 | NeoGenomics Shares Rise After RaDaR ST Assay Gets Expanded Medicare Coverage | MT |
| 08-26 | NeoGenomics Wins Expanded Medicare Coverage for RaDaR ST Immunotherapy Monitoring | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
- Stock Market
- Stocks
- NEO Stock
- Consensus NeoGenomics, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
